GoodRx Holdings (GDRX) Payables (2019 - 2026)

GoodRx Holdings has disclosed Payables across 8 years of filings, most recently posting $8.9 million for Q2 2026.

• In Q2 2026, Payables fell 64.95% year-over-year to $8.9 million; the TTM figure through Jun 2026 stood at $8.9 million (down 64.95% YoY), while the FY2025 annual figure was $19.4 million, up 37.26% from the prior year.
• Payables came in at $8.9 million for Q2 2026 at GoodRx Holdings, down from $14.5 million in the prior quarter.
• In the past five years, Payables ranged from a high of $36.3 million in Q4 2023 to a low of $6.8 million in Q2 2023.
• Average Payables over 5 years is $18.7 million, with a median of $16.0 million recorded in 2022.
• Year-over-year, Payables soared 203.13% in 2023 and sank 64.95% in 2026.
• Over 5 years, Payables stood at $17.7 million in 2022, then jumped by 104.89% to $36.3 million in 2023, then plunged by 61.02% to $14.1 million in 2024, then surged by 37.26% to $19.4 million in 2025, then slumped by 54.1% to $8.9 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $8.9 million in Q2 2026, $14.5 million in Q1 2026, and $19.4 million in Q4 2025.